Co-Authors
This is a "connection" page, showing publications co-authored by Nanshan Zhong and Yonghao Xu.
Connection Strength
1.093
-
Multi-platform omics analysis reveals molecular signature for COVID-19 pathogenesis, prognosis and drug target discovery. Signal Transduct Target Ther. 2021 04 15; 6(1):155.
Score: 0.235
-
Population Bottlenecks and Intra-host Evolution During Human-to-Human Transmission of SARS-CoV-2. Front Med (Lausanne). 2021; 8:585358.
Score: 0.232
-
Clinical Findings of COVID-19 Patients Admitted to Intensive Care Units in Guangdong Province, China: A Multicenter, Retrospective, Observational Study. Front Med (Lausanne). 2020; 7:576457.
Score: 0.227
-
Reply by Xu et al. to Haouzi et al. Am J Respir Crit Care Med. 2020 08 15; 202(4):631-632.
Score: 0.224
-
Secondary infection in severe and critical COVID-19 patients in China: a multicenter retrospective study. Ann Palliat Med. 2021 Aug; 10(8):8557-8570.
Score: 0.060
-
Critical Care Response to the Outbreak of COVID-19: The Experience From Guangdong Province, China. Front Public Health. 2020; 8:576528.
Score: 0.057
-
The incidence, risk factors and prognosis of acute kidney injury in severe and critically ill patients with COVID-19 in mainland China: a retrospective study. BMC Pulm Med. 2020 Nov 09; 20(1):290.
Score: 0.057